Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting illness that can progress to systemic lupus erythematosus (SLE) in approximately 30% of cases. Neurological injuries can occur in both diseases, albeit with distinct presentations.
Wenyi Qin +7 more
doaj +1 more source
Antiphospholipid antibody syndrome (APLAS) characterises a clinical condition of arterial and venous thrombosis associated with phospholipids directed antibodies. APLAS occurs in 2% of the general population. However, one study demonstrated that 7.
Rawat SKS +5 more
doaj
A new approach to antiphospholipid antibody syndrome. [PDF]
Crowther M, Erkan D.
europepmc +1 more source
Retinopathy in a patient with systemic lupus erythematosus
Objective: To descibe a case of bilateral severe ischemic retinopathy in a patient with systemic lupus erythematosus (SLE) and elevated antiphospholipid antibody. Method: This is a case report.
Ildefonso Chan, MD +6 more
doaj
Comprehensive antiphospholipid antibody profiling and unsupervised immune phenotyping in fetal growth restriction. [PDF]
Li S, Shu X, Shi J, Zou J, Wang K.
europepmc +1 more source
Antiphospholipid antibody associated retinal microvascular impairment: a case report and literature review. [PDF]
Wang E, Li J, Sun L, Chen Y, Zhao J.
europepmc +1 more source
A review of the impact of isolated antiphospholipid antibody positivity on pregnancy outcomes and clinical management strategies. [PDF]
Wang X, Ye S, Zhao X, Wang Y.
europepmc +1 more source
Antiphospholipid antibody formation during immune checkpoint inhibition in patients with cancer: a prospective cohort study. [PDF]
Strijdhorst A +7 more
europepmc +1 more source
Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome. [PDF]
Basaran E +4 more
europepmc +1 more source
Antiphospholipid antibody production in pregnant women with SARS-CoV-2 infection and its impact on maternal and fetal outcomes. [PDF]
Ye S +8 more
europepmc +1 more source

